HES 130-0.4 clinical trials
How each study uses HES 130-0.4 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2012 (4)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 13
Regional Hospital Holstebro (3) · Fresenius Kabi (2) · Mansoura University (1) · University Medical Centre Ljubljana (1) · Medical University of Vienna (1) · University Hospital, Linkoeping (1) · Yonsei University (1) · Seoul National University Bundang Hospital (1)
Often tested with
Tested in the same studies.
Sterofundin (1) · Hydroxyethyl Starch Derivatives (1) · Maleimide-polyethylene glycol-modified hemoglobin, MP4 (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses HES 130-0.4 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 16
- Cardiac Output in PreeclampticCompletedNot applicableMansoura UniversityNCT05435573Written as 250 mL 6% hydroxyethyl starch (Voluven) then 500 mL of ringer's acetate solution then 250 mL of 6% hydroxyethyl starch (Voluven)How we know
- Fluid Optimization With Crystalloids and Colloids in NeurosurgeryCompletedNot applicableUniversity Medical Centre LjubljanaNCT03249298Written as Voluven (Bolus of colloids)How we know
- Different Preloads for Prevention of Hypotension in Patients Undergoing Elective CS Under Intrathecal AnesthesiaStatus unknownEarly Phase 1Assiut UniversityNCT03465943Written as VoluvenHow we know
- Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac SurgeryCompletedPhase 4Medical University of ViennaNCT01174719Written as volume replacementHow we know
- Volume Kinetics for Starch Solution and Acetated RingersCompletedNot applicableUniversity Hospital, LinkoepingNCT01195025Written as colloid+acetated RingerHow we know
- Hydroxyethyl Starch and Renal Function After Laparoscopic NephrectomyTerminatedPhase 4Regional Hospital HolstebroNCT01486550Written as Voluven (Hydroxyethyl starch 130/0,4)How we know
- Pulse Pressure Variation for Prediction of Fluid Responsiveness in Coronary Artery Disease Patients With Diastolic DysfunctionCompletedNot applicableYonsei UniversityNCT01819571Written as Fluid loading (Voluven)How we know
- Rotational Thromboelstometry (ROTEM) change_colloid_total Hip Replacement ArthroplastyCompletedNot applicableSeoul National University Bundang HospitalNCT01512628Written as Pentaspan, voluven, volulyteHow we know
- Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1CompletedNot applicableHospices Civils de LyonNCT01972828Written as FLUID MANAGEMENT GUIDED WITH PRELOAD-DEPENDENCE PARAMETERS (VOLUVEN ®)How we know
- Hydroxyethyl Starch and Renal Function After Radical ProstatectomyCompletedPhase 4Regional Hospital HolstebroNCT01486563Written as Voluven (Hydroxyethyl starch 130/0,4)How we know
- Pilot Study of Hemospan® in Patients With Chronic Critical Limb IschemiaCompletedPhase 2SangartNCT00633659Written as Voluven (HES 130/0.4)How we know
- Hydroxyethyl Starch and Renal Function After Hip Replacement SurgeryCompletedPhase 4Regional Hospital HolstebroNCT01486576Written as Voluven (Hydroxyethyl starch 130/0,4)How we know
- Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe SepsisCompletedPhase 3Fresenius KabiNCT00464204Written as 6 % Hydroxyethylstarch 130/0.4 = "Voluven®"How we know
- Voluven® in Paediatric PatientsCompletedPhase 4Fresenius KabiNCT00860405Written as HES 130/0.4 (6%) in sodium chloride (Voluven®, solution for infusion), Human serum albumin (HSA 50g/L)How we know
- BaSES Trial: Basel Starch Evaluation in SepsisCompletedPhase 4University Hospital, Basel, SwitzerlandNCT00273728Written as hydroxy-ethyl starch (MW 130; 0.4) vs. normal salineHow we know
- Colloids in Severe TraumaCompletedPhase 4University of the PhilippinesNCT00890383Written as tetrastarch (Voluven)How we know
As the comparator · 5 — what is tested is compared with HES 130-0.4
- Colloids in Pediatric Cardiac Surgery: Comparison Between a Balanced and a Non-balanced ColloidCompletedPhase 3Queen Fabiola Children's University HospitalNCT02584868Written as Hydroxyethyl starch 130/0.4 in 0.9% sodium chlorideHow we know
- Phase III Study of Hemospan® to Prevent Hypotension in Hip ArthroplastyCompletedPhase 3SangartNCT00421200Written as Voluven (HES 130/0.4)How we know
- Phase III Study of Hemospan® for Treating Hypotension in Hip ArthroplastyCompletedPhase 3SangartNCT00420277Written as Voluven (HES 130/0.4)How we know
- Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG PatientsCompletedPhase 4Innogene Kalbiotech Pte. LtdNCT01654653Written as 6% Hydroxy Ethyl StarchHow we know
- Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary RevascularizationCompletedPhase 2Biopure CorporationNCT00317512Written as VoluvenHow we know